Public Meeting of the Presidential Commission for the Study of Bioethical Issues, 5766 [2016-01982]

Download as PDF 5766 Federal Register / Vol. 81, No. 22 / Wednesday, February 3, 2016 / Notices 21 CFR part 314 for NDAs and ANDAs have been approved under OMB control number 0910–0001. The collections of information in 21 CFR part 601 for BLAs have been approved under OMB control number 0910–0338. The collections of information in 21 CFR part 814, subparts B and E, for PMAs have been approved under OMB control number 0910–0231. The collections of information in 21 CFR part 814, subpart H, for humanitarian device exemption applications have been approved under OMB control number 0910–0332. The collections of information in 21 CFR part 807, subpart E, for 510(k) notifications have been approved under OMB control number 0901–0120. The collections of information in 21 CFR part 312 for INDs have been approved under OMB control number 0910–0014. The collections of information in 21 CFR part 812 for IDEs have been approved under OMB control number 0910–0078. The collections of information in 21 CFR part 820 for the quality system regulation have been approved under OMB control number 0910–0073. Dated: January 28, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–01888 Filed 2–2–16; 8:45 am] BILLING CODE 4161–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Meeting of the Presidential Commission for the Study of Bioethical Issues Presidential Commission for the Study of Bioethical Issues, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice of meeting. AGENCY: The Presidential Commission for the Study of Bioethical Issues (the Commission) will conduct its twenty fourth meeting on March 3, 2016. At this teleconference meeting, the Commission will discuss its ongoing development of pedagogical materials to facilitate the integration of bioethics into education in a range of traditional and non-traditional settings. DATES: The teleconference meeting will take place March 3, 2016, from 2 p.m. to approximately 4 p.m. ADDRESSES: The public teleconference will be conducted by telephone only. The agenda and call-in number will be posted at least one week in advance at http://www.bioethics.gov. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 19:14 Feb 02, 2016 Jkt 238001 Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. Telephone: 202–233–3960. Email: Lisa.Lee@bioethics.gov. Additional information may be obtained at www.bioethics.gov. FOR FURTHER INFORMATION CONTACT: Pursuant to the Federal Advisory Committee Act of 1972, Public Law 92–463, 5 U.S.C. app. 2, notice is hereby given of the twenty fourth meeting of the Commission. The public teleconference will be open to the public with attendance limited to space available. Under authority of Executive Order 13521, dated November 24, 2009, the President established the Commission. The Commission is an expert panel of not more than 13 members who are drawn from the fields of bioethics, science, medicine, technology, engineering, law, philosophy, theology, or other areas of the humanities or social sciences. The Commission advises the President on bioethical issues arising from advances in biomedicine and related areas of science and technology. The Commission seeks to identify and promote policies and practices that ensure scientific research, health care delivery, and technological innovation are conducted in a socially and ethically responsible manner. The main agenda for the Commission’s twenty fourth meeting is to discuss its ongoing development of pedagogical materials to facilitate the integration of bioethics into education in a range of traditional and nontraditional settings. The draft meeting agenda, call-in number, and other information about the Commission will be available at www.bioethics.gov. The Commission welcomes input from anyone wishing to provide public comment on any issue before it. Respectful consideration of opposing views and active participation by citizens in public exchange of ideas enhances overall public understanding of the issues at hand and conclusions reached by the Commission. The Commission is particularly interested in receiving comments and questions during the meeting that are responsive to specific sessions. Written comments will be accepted in advance, during, and after the meeting and are especially welcome. Comments will be publicly available, including any personally identifiable or confidential business information that they contain. Trade secrets should not be submitted. Written comments will be accepted by email to info@bioethics.gov, or by mail SUPPLEMENTARY INFORMATION: PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 to the following address: Public Commentary, Presidential Commission for the Study of Bioethical Issues, 1425 New York Avenue NW., Suite C–100, Washington, DC 20005. To accommodate as many individuals as possible, the time for each question or comment may be limited. If the number of individuals wishing to pose a question or make a comment is greater than can reasonably be accommodated during the scheduled meeting, the Commission may make a random selection. Anyone planning to call into the meeting, who needs special assistance or other reasonable accommodations, should notify Esther Yoo by telephone at (202) 233–3960, or email at Esther.Yoo@bioethics.gov in advance of the meeting. The Commission will make every effort to accommodate persons who need special assistance. Dated: January 20, 2016. Lisa M. Lee, Executive Director, Presidential Commission for the Study of Bioethical Issues. [FR Doc. 2016–01982 Filed 2–2–16; 8:45 am] BILLING CODE 4154–06–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Presidential Advisory Council on HIV/AIDS; Correction Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. AGENCY: ACTION: Notice; correction. The meeting of the Presidential Advisory Council on HIV/ AIDS (PACHA) scheduled for January 28 and 29, 2016, is postponed due to inclement weather. This meeting will be rescheduled at a future date. SUMMARY: FOR FURTHER INFORMATION CONTACT: Caroline Talev, MPA, Committee Manager, Hubert Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 202– 205–1178. Fax: 202–401–4005. Email: Caroline.Talev@hhs.gov. Correction In the Federal Register of January 5, 2016, Vol. 81, No. 2, on pages 243–244 a meeting of the Presidential Advisory Council on HIV/AIDS was announced. That meeting has been cancelled due to inclement weather. E:\FR\FM\03FEN1.SGM 03FEN1

Agencies

[Federal Register Volume 81, Number 22 (Wednesday, February 3, 2016)]
[Notices]
[Page 5766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01982]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the Presidential Commission for the Study of 
Bioethical Issues

AGENCY: Presidential Commission for the Study of Bioethical Issues, 
Office of the Assistant Secretary for Health, Office of the Secretary, 
Department of Health and Human Services.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Presidential Commission for the Study of Bioethical Issues 
(the Commission) will conduct its twenty fourth meeting on March 3, 
2016. At this teleconference meeting, the Commission will discuss its 
ongoing development of pedagogical materials to facilitate the 
integration of bioethics into education in a range of traditional and 
non-traditional settings.

DATES: The teleconference meeting will take place March 3, 2016, from 2 
p.m. to approximately 4 p.m.

ADDRESSES: The public teleconference will be conducted by telephone 
only. The agenda and call-in number will be posted at least one week in 
advance at http://www.bioethics.gov.

FOR FURTHER INFORMATION CONTACT: Lisa M. Lee, Executive Director, 
Presidential Commission for the Study of Bioethical Issues, 1425 New 
York Avenue NW., Suite C-100, Washington, DC 20005. Telephone: 202-233-
3960. Email: Lisa.Lee@bioethics.gov. Additional information may be 
obtained at www.bioethics.gov.

SUPPLEMENTARY INFORMATION: Pursuant to the Federal Advisory Committee 
Act of 1972, Public Law 92-463, 5 U.S.C. app. 2, notice is hereby given 
of the twenty fourth meeting of the Commission. The public 
teleconference will be open to the public with attendance limited to 
space available.
    Under authority of Executive Order 13521, dated November 24, 2009, 
the President established the Commission. The Commission is an expert 
panel of not more than 13 members who are drawn from the fields of 
bioethics, science, medicine, technology, engineering, law, philosophy, 
theology, or other areas of the humanities or social sciences. The 
Commission advises the President on bioethical issues arising from 
advances in biomedicine and related areas of science and technology. 
The Commission seeks to identify and promote policies and practices 
that ensure scientific research, health care delivery, and 
technological innovation are conducted in a socially and ethically 
responsible manner.
    The main agenda for the Commission's twenty fourth meeting is to 
discuss its ongoing development of pedagogical materials to facilitate 
the integration of bioethics into education in a range of traditional 
and non-traditional settings. The draft meeting agenda, call-in number, 
and other information about the Commission will be available at 
www.bioethics.gov.
    The Commission welcomes input from anyone wishing to provide public 
comment on any issue before it. Respectful consideration of opposing 
views and active participation by citizens in public exchange of ideas 
enhances overall public understanding of the issues at hand and 
conclusions reached by the Commission. The Commission is particularly 
interested in receiving comments and questions during the meeting that 
are responsive to specific sessions. Written comments will be accepted 
in advance, during, and after the meeting and are especially welcome. 
Comments will be publicly available, including any personally 
identifiable or confidential business information that they contain. 
Trade secrets should not be submitted.
    Written comments will be accepted by email to info@bioethics.gov, 
or by mail to the following address: Public Commentary, Presidential 
Commission for the Study of Bioethical Issues, 1425 New York Avenue 
NW., Suite C-100, Washington, DC 20005. To accommodate as many 
individuals as possible, the time for each question or comment may be 
limited. If the number of individuals wishing to pose a question or 
make a comment is greater than can reasonably be accommodated during 
the scheduled meeting, the Commission may make a random selection.
    Anyone planning to call into the meeting, who needs special 
assistance or other reasonable accommodations, should notify Esther Yoo 
by telephone at (202) 233-3960, or email at Esther.Yoo@bioethics.gov in 
advance of the meeting. The Commission will make every effort to 
accommodate persons who need special assistance.

     Dated: January 20, 2016.
Lisa M. Lee,
Executive Director, Presidential Commission for the Study of Bioethical 
Issues.
[FR Doc. 2016-01982 Filed 2-2-16; 8:45 am]
BILLING CODE 4154-06-P